全文获取类型
收费全文 | 768篇 |
免费 | 21篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 18篇 |
妇产科学 | 28篇 |
基础医学 | 86篇 |
口腔科学 | 14篇 |
临床医学 | 65篇 |
内科学 | 148篇 |
皮肤病学 | 39篇 |
神经病学 | 30篇 |
特种医学 | 28篇 |
外科学 | 84篇 |
综合类 | 30篇 |
一般理论 | 1篇 |
预防医学 | 73篇 |
眼科学 | 6篇 |
药学 | 93篇 |
肿瘤学 | 35篇 |
出版年
2013年 | 7篇 |
2012年 | 4篇 |
2010年 | 9篇 |
2009年 | 6篇 |
2007年 | 5篇 |
2006年 | 3篇 |
2001年 | 10篇 |
2000年 | 6篇 |
1999年 | 7篇 |
1998年 | 15篇 |
1997年 | 12篇 |
1996年 | 28篇 |
1995年 | 14篇 |
1994年 | 12篇 |
1993年 | 18篇 |
1992年 | 13篇 |
1991年 | 18篇 |
1990年 | 12篇 |
1989年 | 15篇 |
1988年 | 14篇 |
1987年 | 10篇 |
1986年 | 17篇 |
1985年 | 3篇 |
1984年 | 7篇 |
1983年 | 8篇 |
1982年 | 12篇 |
1981年 | 8篇 |
1980年 | 7篇 |
1979年 | 8篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1976年 | 4篇 |
1975年 | 5篇 |
1971年 | 3篇 |
1965年 | 4篇 |
1964年 | 4篇 |
1963年 | 9篇 |
1961年 | 4篇 |
1960年 | 9篇 |
1959年 | 36篇 |
1958年 | 63篇 |
1957年 | 58篇 |
1956年 | 64篇 |
1955年 | 56篇 |
1954年 | 38篇 |
1950年 | 3篇 |
1949年 | 26篇 |
1948年 | 48篇 |
1946年 | 9篇 |
1927年 | 2篇 |
排序方式: 共有789条查询结果,搜索用时 15 毫秒
1.
2.
Glossopharyngeal tic douloureux or neuralgia is a comparatively rare but well-recognized syndrome. In respect to the stabbing paroxysmal nature of the pain and its relation to specific trigger zones, it is exactly comparable to the commoner trigeminal tic douloureux. In neurosurgical clinics the two types of neuralgia occur in a ratio of about one to forty.The significance of cardiac arrest and syncope associated with glossopharyngeal neuralgia was first emphasized by Riley and associates,1 in a brief report of two cases in 1942. This report called attention to the afferent pathway of the carotid sinus reflex through the glossopharyngeal nerve and suggested the correlation of the simultaneous neuralgia and excessive stimuli to the sinus reflex. Neither of the two cases was reported to have been subjected to operation. Since then, no other reports of similar cases have come to light in medical literature. However, one of us (Ray) had the opportunity of examining such a case with Dr. Jefferson Browder in 1943 and this patient was relieved of all symptoms by intracranial section of the glossopharyngeal nerve.Because of the importance of further establishing the authenticity of the syndrome and calling wider attention to the importance of its recognition, there is justification for reporting another comparable case. 相似文献
3.
BERNHARD FREY MICHAEL WUTTE RUDOLF BERGER CLEANTHIS IOANNIDES MARTIN HÜLSMANN BRIGITTE STANEK RICHARD PACKER 《Pacing and clinical electrophysiology : PACE》1995,18(1):152-158
To investigate the impact of staged therapy for advanced heart failure on therapeutic endpoints, 236 consecutive patients (coronary artery disease/dilated cardiomyopathy in 61/175 patients, left ventricular ejection fraction 14%± 5%, New York Heart Association Class IIl/IIIIV in 102/79/55 patients, respectively) with advanced heart failure were prospectively followed. One hundred thirtyseven patients enrolled from January 1989 to December 1991 were treated conventionally with digoxin, furosemide, and low dose angiotension converting enzyme (ACE) inhibition. Patients refractory to this therapy underwent urgent heart transplantation. Ninetynine patients enrolled from January 1992 to August 1993 underwent staged therapy: stage 1: maximal tolerated ACE inhibition; stage 2: therapy with PGE1 for preand afterload reduction to achieve hemodynamic stabilization; or stage 3: refractory patients bridged to heart transplantation with continuous outpatient dobutamine. Sudden death was defined as death within 1 hour of symptoms if heart failure symptoms remained stable over the previous 7 days. Conventionally treated patients were followed for 10 ± 9 months; patients who underwent staged therapy for 9 ±5 months. In the group of patients that underwent standard therapy, 39 of 137 (28%) patients died: 5 (13%) deaths occurred suddenly, and death due to progressive pump failure occurred in the remaining 34 (87%) patients. In the group of patients that underwent staged therapy, 25 of 99 (25%) patients died: 13 (52%) deaths occurred suddenly, and 12 (48%) deaths occurred due to progressive pump failure. Thus, patients who underwent staged therapy were at increased risk for sudden death (P = 0.01, relative risk 3.4, 95% confidence interval 1.2–9.7) but were at lower risk for death from pump failure (P = 0.009, relative risk 0.44, 95% confidence interval 0.22–0.84). In patients who underwent therapy with continuous outpatient PGE1 (n = 7) or dobutamine (n= 21), risk for sudden death (P = NS by log rank test) did not increase. In conclusion, staged therapy significantly reduced death from pump failure; however, patients who could be stabilized and considered too well for heart transplantation were at increased risk for sudden death. Thus, overall survival did not improve. Of note, outpatient dobutamine did not increase the risk for sudden death. 相似文献
4.
5.
P.F. MORSE D.F. HORROBIN M.S. MANKU J.C.M. STEWART R. ALLEN S. LITTLEWOOD S. WRIGHT† J. BURTON† D.J. GOULD‡ P.J. HOLT§ C.T. JANSEN¶ L. MATTILA¶ W. MEIGEL TH. DETTKE D. WEXLER†† L. GUENTHER†† A. BORDONI‡‡ A. PATRIZI‡‡ 《The British journal of dermatology》1989,121(1):75-90
Gamma-linolenic acid in the form of a particular variety of evening primrose oil (Epogam) has been reported of value in the treatment of atopic eczema. Nine controlled trials of evening primrose oil were performed in eight centres. Four of the trials were parallel and five cross-over. Doctors and patients assessed the severity of eczema by scoring measures of inflammation, dryness, scaliness, pruritus and overall skin involvement. Individual symptom scores were combined to give a single global score at each assessment point. In the analysis of the parallel studies, both patient and doctor scores showed a highly significant improvement over baseline (P less than 0.0001) due to Epogam: for both scores the effect of Epogam was significantly better than placebo. Similar results were obtained on analysis of the cross-over trials, but in this case the difference between Epogam and placebo in the doctors' global score, although in favour of Epogam, failed to reach significance. The effects on itch were particularly striking. There was no placebo response to this symptom, whereas there was a substantial and highly significant response to Epogam (P less than 0.0001). When the improvements, or otherwise, in clinical condition were related to changes in plasma levels of dihomogammalinolenic and arachidoni acids, it was found that there was a positive correlation between an improvement in clinical score and a rise in the fatty acid levels. 相似文献
6.
7.
Deaths from sudden infant death syndrome (SIDS) between 1979 and 1984 were tabulated by month for weekdays, weekends and public holidays. Examination of deaths by day of the week showed the weekend had more deaths than the weekdays (χ2 = 26.3, df = 6, p = 0.0002) and that this pattern occurred in both the under three months and three-11 months age group. There were 40 deaths on the 78 public holidays in the six years under study. Modelling the data showed that there was no difference between the number of deaths on holidays compared to weekends. 相似文献
8.
KOIPLOVITZ I.; HARRIS L. W.; ANDERSON D. R.; LENNOX W. J.; STEWART J. R. 《Toxicological sciences》1992,18(1):102-106
Reduction by Pyridostiginine Pretreatment of the Efficacy ofAtropine and 2-PAM Treatment of Sarin and VX Poisoning in Rodents.KOPLOVITZ, I., HARRIS, L. W., ANDERSON, D. R., LENNOX, W. J.,AND STEWART, J. R. (1992). Fundam. Appl. Toxicol. 18, 102106. This study concerned the effect of pyridostigmine pretreatmenton (a) the antidotal efficacy of atropine and 2-PAM in sarin,tabun, and VX poisoning in mice and guinea pigs and on (b) theoxime-induced reactivation of VX-inhibited whole blood acetyicholinesterase(AChE) of guinea pigs. One hour prior to organophosphate (OP)challenge with sarin, tabun, or VX, animals were given oraldoses of pyridostiginine to induce approximately 30 and 60%inhibition of whole blood AChE; controls received vehicle. Micewere challenged im and guinea pigs sc with the OP compounds.Treatment with atropine (11.2 mg/kg to mice; 32 mg/kg to guineapigs) plus 2-PAM (25 mg/kg) was given im at 10 sec postchallengein mice and 1 min postchallenge in guinea pigs. In the reactivationexperiments, pyridostigmine or saline was given im to guineapigs 30 min prior to VX (8.24 µg/kg, sc), atropine (16mg/kg) was given im at 1 mm, and 2-PAM (25 mg/kg) at 16 minpostchallenge. Pyridostigmine significantly enhanced the efficacyof atropine and 2-PAM against tabun in both species. In contrast,pyridostigmine reduced or did not increase the efficacy of atropineand 2-PAM against sarin or VX in both species. Recovery of VX-inhibitedAChE by 2-PAM was decreased significantly in pyridostigminepretreated animals. The results suggest that pyridostigminepretreatment may adversely effect the efficacy of atropine and2-PAM as antidotes for VX and sarin intoxication. 相似文献
9.
10.